Regulations | Science and Enterprise

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
about 19 hours ago
New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
about 19 hours ago
I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
about 2 days ago
Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
about 3 days ago
A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
about 3 days ago

Infographic – Public Favors Rejoining Paris Accord

By Alan, on November 28th, 2020%

A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agreement. . . . → Read More: Infographic – Public Favors Rejoining Paris Accord

Trial Requested for Covid-19 Vaccine Nasal Spray

By Alan, on November 27th, 2020%

Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine. . . . → Read More: Trial Requested for Covid-19 Vaccine Nasal Spray

FDA Grants Emergency Clearance for Home Covid-19 Test

By Alan, on November 18th, 2020%

The Food and Drug Administration gave an emergency authorization for a self-collected Covid-19 diagnostic test, the first such test for home use. . . . → Read More: FDA Grants Emergency Clearance for Home Covid-19 Test

ALS Stem Cell Therapy Fails to Meet Trial Objective

By Alan, on November 17th, 2020%

Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective

Infographic: U.S. Public Supports Lockdown

By Alan, on November 14th, 2020%

With Covid-19 cases in the U.S. accelerating in the past few weeks, a recent poll shows the public clearly favors a lockdown to stop the rise. . . . → Read More: Infographic: U.S. Public Supports Lockdown

Covid-19 Saliva Test Earns FDA Emergency Clearance

By Alan, on November 12th, 2020%

A test to detect Covid-19 viruses in saliva rather than nasal swabs received emergency authorization from Food and Drug Administration. . . . → Read More: Covid-19 Saliva Test Earns FDA Emergency Clearance

FDA Issues Guidance to Boost Clinical Trial Diversity

By Alan, on November 9th, 2020%

Food and Drug Administration issued new regulatory guidance designed to enroll clinical trial participants more representative of the populations they claim to serve. . . . → Read More: FDA Issues Guidance to Boost Clinical Trial Diversity

Infographic – U.S. Public Split on Contact Tracing

By Alan, on November 7th, 2020%

While majorities of Americans say they’re willing to take part in contact tracing activities during the Covid-19 pandemic, large parts of the public are still reluctant. . . . → Read More: Infographic – U.S. Public Split on Contact Tracing

FDA to Use Lung Chip Model for Covid-19 Testing

By Alan, on October 30th, 2020%

The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes. . . . → Read More: FDA to Use Lung Chip Model for Covid-19 Testing

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

By Alan, on October 27th, 2020%

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise